Apalutamide will minimize the extent or outcome of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of apalutamide, a robust CYP3A4 inducer, with medications that happen to be CYP3A4 substrates may result in decrease exposure to those medications. calaspargase pegol, ethinylestradiol. unidentified system. Stay away https://andresbktdl.vblogetin.com/35823675/5-simple-techniques-for-buy-wymzya-fe